Learn More
Medchemexpress LLC Agi-5198 (idh-c35) | 1355326-35-0 | 99.9% | 462.56 | 1 ML

Supplier: Medchemexpress LLC HY1808210MM/1ML
AGI-5198 (IDH-C35) is a potent and selective mutant IDH1R132H inhibitor with an IC50 of 0.07 μM.
- Demonstrates dose-dependent inhibition of mutant IDH1 enzyme in TS603 glioma cells.
- Does not impair colony formation of patient-derived glioma lines expressing only wild-type IDH1.
- Reverses increased reactive oxygen species, DNA double-strand breaks, and cell death in IDH1(R132H) cancer cells exposed to ionizing radiation.
- Causes 50 to 60% growth inhibition of human glioma xenografts in vivo.
- Reduces Ki-67 protein staining in tumors from treated mice.
- Does not affect the growth of IDH1 wild-type glioma xenografts.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.